• Home>
  • Stocks>
  • Krebs Biochemicals & Industries Ltd Share Price
Krebs Biochemicals & Industries Ltd share price logo

Krebs Biochemicals & Industries Ltd Share Price (KREBSBIO)

₹74.890.44%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Krebs Biochemicals & Industries Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹74
    ₹77.9
    downward going graph

    1.19%

    Downside

    4.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹66.12
    ₹129.07
    downward going graph

    11.71%

    Downside

    72.35%

    Upside

    downward going graph
Previous Close₹74.56
Open₹74.00
Volume2,676.00
Upper Circuit₹78.28
Lower Circuit₹70.83
Day's Low74
Day's High77.9
52 Week Low66.12
52 Week High129.07
1 Month Return-8.74 %
3 Month Return+ 2.24 %
1 Year Return-13.94 %
3 Year Return-34.34 %
5 Year Return-14.59 %

Krebs Biochemicals & Industries Ltd Stock Fundamentals & Key Indicators

Check Krebs Biochemicals & Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹160.76 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

1.26

P/B Ratio

-1.1

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

2.9

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Krebs Biochemicals & Industries Ltd Stock's Interest Amongst Investors

-43%

Period Aug 23, 2025 to Jul 24, 2025. Change in 30 Days vs previous period

Search interest for Krebs Biochemicals & Industries Ltd Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Krebs Biochemicals & Industries Ltd Financial Results

Get the annual and quarterly financial summary of Krebs Biochemicals & Industries Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

13 (0%)13 (0%)11 (11%)6 (47%)5 (10%)
Net Income

(in ₹ Cr)

-5 (0%)-6 (11%)-8 (34%)-8 (7%)-5 (36%)
Net Profit Margin-40.11% (0%)-44.79% (12%)-67.48% (51%)-135.57% (101%)-97.08% (28%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

159 (0%)190 (19%)175 (8%)178 (2%)
Total Liabilities

(in ₹ Cr)

172 (0%)135 (22%)144 (7%)167 (16%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-36 (0%)-15 (59%)-17 (18%)-25 (44%)2 (109%)

Krebs Biochemicals & Industries Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Krebs Biochemicals & Industries Ltd.

  • Krebs Biochemicals & Industries Ltd Earnings Results

    Krebs Biochemicals & Industries Ltd’s net profit fell -2.9% since last year same period to ₹-5.32Cr in the Q1 2025-2026. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated 35.67% jump in its net profits since last 3-months.

    Read More about Earnings Results

Krebs Biochemicals & Industries Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Krebs Biochemicals & Industries Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
72.74%
0.00
Foreign Institutions
0.49%
0.00
Mutual Funds
0%
0.00
Retail Investors
26.76%
0.00
Others
0.01%
0.00

Krebs Biochemicals & Industries Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Krebs Biochemicals & Industries Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA160.76-2.92%0.00-2050
NA144.7017.83%0.847339
NA509.1222.09%0.00NANA
NA732.0831.15%0.514211,280
NA6.03-7.89%0.00-6NA

Krebs Biochemicals & Industries Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Krebs Biochemicals & Industries Ltd.

  • Krebs Biochemicals Reports Significant Losses - 21 May, 2025

    Krebs Biochemicals & Industries reported a standalone net loss of Rs 8.27 crore for Q1 March 2025, a decline from Rs 5.85 crore in Q1 March 2024. Sales fell 49.04% to Rs 6.10 crore. For the full year, net loss reached Rs 26.94 crore, compared to Rs 19.73 crore the previous year, with annual sales down 14.10% to Rs 43.31 crore.

Insights on Krebs Biochemicals & Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 26.76% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.49% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 36.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 173.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.74% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KREBSBIO stock has moved down by -2.1%

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals Industries Ltd. (KBIL) is a fermentation-based active pharmaceutical ingredient (API) manufacturer. Established in 1991, KBL has grown to a capacity of 150 TPA since launching its commercial operations in 1994. KBL has developed global capabilities in fermentation technology, resulting in successful launches over a two-year period (200102) of Vitamin CIP Grade via fermentation. The company has ISO 9002 certifications for its unit I at Nellore and produces and markets Lovastatin, Simvastatin, and Vitamin C. KBL is also in the process of building a cogeneration power plant at unit II. It has also successfully bidded for Nannapaneni Venkatrao Cooperative Sugars Ltd located at Jampani, Guntur District, Andhra Pradesh in December 2003.

Revenue: ₹5.48Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-5.32Cr as on June 2025 (Q1 FY26)
Listing date: 28 Aug, 1995
Chairperson Name: R T Ravi
OrganisationKrebs Biochemicals & Industries Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOR T Ravi
E-voting on sharesClick here to vote

FAQs

What is Krebs Biochemicals & Industries Ltd share price today?

Krebs Biochemicals & Industries Ltd share price today stands at ₹74.89, Open: ₹74, Previous Close: ₹74.56, High: ₹77.9, Low: ₹74, 52 Week High: ₹129.07, 52 Week Low: ₹66.12 as on .

How to buy Krebs Biochemicals & Industries Ltd shares ?

To buy Krebs Biochemicals & Industries Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KREBSBIO or Krebs Biochemicals & Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Krebs Biochemicals & Industries Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Krebs Biochemicals & Industries Ltd?

Today's traded volume of Krebs Biochemicals & Industries Ltd is 2,676.00. Which means that 2,676.00 shares of Krebs Biochemicals & Industries Ltd were bought and sold on the stock market during today's trading session.

What is Krebs Biochemicals & Industries Ltd's market cap today?

Today's market capitalisation of Krebs Biochemicals & Industries Ltd is ₹160.76 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Krebs Biochemicals & Industries Ltd?

Krebs Biochemicals & Industries Ltd’s 52 week high is ₹129.07 and 52 week low is ₹66.12. The current share price of Krebs Biochemicals & Industries Ltd is ₹74.89, which is -41.98% down from its 52 week high and 13.26% up from its 52 week low.